NFKB1 and prostate carcinoma: NF-κB is a transcription factor that is associated with inflammatory responses, Withaferin A treatment has been observed to inhibit NF-κB, suppress the nuclear translocation of its p65 subunit, and downregulate p65 in prostate cancer and soft tissue sarcoma cells (Vyasand Singh, 2014).